Point of CARE testing in a general practice setting trial

Recruiting

• Conditions: Diabetes; Hyperlipidaemia and anticoagulantm therapy; Metabolic and Endocrine - Diabetes; Diet and Nutrition - Other diet and nutrition disorders

• Registration Number: ACTRN12605000272695
• Lead Sponsor: Department of General Practice, The University of Adelaide

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 6836

Inclusion Criteria

Have an established disease. The criteria for categorising a patient as having established disease are: 1. Anticoagulant therapy patient has been prescribed warfarin and has had INR test results within the therapeutic range for at least one month (i.e. is stabilised). 2. Diabetes patient has had a fasting plasma glucose > = 7.0 mmol/L or 2-hour post glucose load >=11.1 mmol/L. 3. Hyperlipidaemia patient is, or has been, eligible for pharmaceutical benefits for lipid lowering drugs (statins).

Exclusion Criteria

Patients who have significant cognitive impairment (eg dementia), and/or Patients unable to understand the instructions written in English, and/or patients who have poor insight into their disease process or physical disabilities.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
improved control for patients with lipids, diabetes and INR[At 18 months]

Secondary Outcome Measures

Name	Time	Method
1) safety (competency, quality asurance, quality control and precision and accuracy)[6 months];2) Cost effectiveness of PoCT[18 months];3) Satisfaction with PoCT (GPs, patients, practice staff, other stakeholders).[17 month]